Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that new data on the company’s ...

Quince Therapeutics advances Ataxia-Telangiectasia treatment with innovative AIDE platform, insider support, and NEAT Phase 3 ...

Over the past several years, we’ve all learned more about the potentially dangerous consequences of being bitten by a tick.

After a patient died following a high dose of Neurogene’s Rett syndrome gene therapy candidate, the biotech is sharing ...

Melphalan/hepatic delivery system showed better survival and response rates than best alternative care in metastatic uveal ...

Beam to Host Investor Webcast on Friday, June 13, 2025, at 4:00 p.m. ET ...

A surge of attention is sweeping through the wellness community as the newly redesigned Mitolyn.com unveils bold claims and ...

Discover the signs of Lyme disease that everyone must recognize, from the classic bull's-eye rash to neurological symptoms ...

The evolution of Type 5 diabetes encompasses undernutrition in the womb along with undernutrition in childhood. This has been ...

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced its abstract has been selected for a poster presentation at ...

With over 800,000 customers across more than 20 countries, PhytAge Labs has carved out a reputation as a leader in ...

A vengeful Phyllis strikes a deal with Victor, Chelsea and Adam face turbulence, and Lily grows closer to Damian in Tuesday’s ...